Lisinopril for severe congestive heart failure
- 1 February 1989
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 63 (8) , D8-D11
- https://doi.org/10.1016/0002-9149(89)90410-4
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Modulation of hemodynamic effects with a converting enzyme inhibitor: Acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responsesAmerican Heart Journal, 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Comparison of Captopril and Enalapril in Patients with Severe Chronic Heart FailureNew England Journal of Medicine, 1986
- EnalaprilDrugs, 1986
- Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failureJournal of the American College of Cardiology, 1985
- Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study.Circulation, 1984
- A placebo-controlled trial of captopril in refractory chronic congestive heart failureJournal of the American College of Cardiology, 1983
- The effect of captopril on renal, coronary, and systemic hemodynamics in patients with severe congestive heart failureAmerican Heart Journal, 1982
- Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.Circulation, 1980
- An Algorithm for Least-Squares Estimation of Nonlinear ParametersJournal of the Society for Industrial and Applied Mathematics, 1963